Enzyme vs Tuebora: Revenue, Funding & Team Size Compared
Enzyme generates $10.3M in revenue; Tuebora generates $10.5M. Tuebora and Enzyme are close to the same size by revenue. The table below compares Enzyme and Tuebora on funding, valuation, customers, team size and headquarters — every figure GetLatka has verified for each company.
| Company |  EnzymeThis company |  Tuebora |
|---|---|---|
| Revenue | $10.3M | $10.5M |
| Valuation | $61.6M | $73.5M |
| Funding raised | $2M | Not disclosed |
| Customers | 21 | Not disclosed |
| Team size | 33 | 37 |
| Founded | 2018 | 2011 |
| HQ | San Francisco, United States | Santa Clara, United States |
Want the full dataset? GetLatka tracks revenue, funding and team history for thousands of SaaS companies, with charts, growth rates and founder interviews.
Enzyme at a glance
Enzyme generates $10.3M in revenue with 33 employees, headquartered in San Francisco, United States.
- Revenue
- $10.3M
- Valuation
- $61.6M
- Funding
- $2M
- Customers
- 21
- Team size
- 33
- Founded
- 2018
Automating FDA approval and compliance
Tuebora at a glance
Tuebora generates $10.5M in revenue with 37 employees, headquartered in Santa Clara, United States.
- Revenue
- $10.5M
- Valuation
- $73.5M
- Team size
- 37
- Founded
- 2011
Tuebora offers the most Agile, Adaptive and Real-time Identity and Access Management/Governance Solution as a Service for organizations of all sizes.
Other Enzyme alternatives
Enzyme competes with more than the companies on this page. Browse the full alternative lists to compare revenue, funding and team size across the category.
Enzyme vs Tuebora: frequently asked questions
Is Enzyme or Tuebora bigger?
Tuebora is the bigger company by revenue, at $10.5M against $10.3M for Enzyme.
How much revenue does Enzyme make?
Enzyme generates $10.3M in annual revenue with a team of 33.
How much revenue does Tuebora make?
Tuebora generates $10.5M in annual revenue with a team of 37.
How much funding has Enzyme raised?
Enzyme has raised $2M in total funding since it was founded in 2018.